Pilot Study to Assess the Feasibility of Randomizing Extended Length of Stay in Medically Managed Opioid Withdrawal

How to cite

Jacobson, Mireille; Chang, Tom; Powell, David. 2025. "Pilot Study to Assess the Feasibility of Randomizing Extended Length of Stay in Medically Managed Opioid Withdrawal." AEA RCT Registry. AEARCTR-0016250. https://doi.org/10.1257/rct.16250-1.0

Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.

Mireille Jacobson* , Tom Chang , David Powell

* Primary investigator

Registry ID
AEARCTR-0016250
DOI
https://doi.org/10.1257/rct.16250-1.0
First registered
Last updated
Status
In development
Trial dates
2025-07-07 – 2026-06-01
Countries
Private
Registry record
http://www.socialscienceregistry.org/trials/16250

Abstract

Provisional CDC data indicate that nationwide opioid overdose deaths declined rapidly between December 2023 and 2024, but overdose deaths remain high and many individuals still struggle with opioid use disorder. In this collaboration with Pierce County, WA, the second most populous county in Washington, and the Metropolitan Development Council (MDC), a social service provider in the county, we will test the feasibility of randomizing length of stay for individuals undergoing medically managed withdrawal (detox) from fentanyl. While providers of medically managed detox services believe that 10-15 days constitute the optimal length of stay, insurers typically only cover detox stays of five days and some patients leave even prior to that. This work will assess whether expanding coverage to more than five days can increase the completed length of stay in detox. We will also collect and analyze data on the reasons people leave detox “Against Medical Advice” or AMA. Findings will inform a larger study on the impact of detox length of stay on patient outcomes such as entry into treatment, return to detox and health care utilization. It will also generate insights into strategies to reduce AMA departures.

Intervention

Patients presenting for medically managed detox from fentanyl will be randomized to a standard or extend length of stay. Staff provide details on the covered length of stay at a planning meeting that usually occurs on the 2nd day in detox. We will provide a randomization sequence for length of stay offers to patients who are admitted for detox from fentanyl. Patients admitted for detox from other substances, most commonly alcohol or some combination of substances, will not be included in the offer per Pierce County and MDC agreement.

Experimental design

Patients presenting for medically managed detox from fentanyl will be randomized to coverage of a standard detox stay or and extend length of stay.

Design details

Randomization method
Done by research team on a computer with sequence of randomization provided to intake coordinator
Randomization unit
Patient
Clusters
0 clusters
Observations
400
Arms
200
Primary outcomes
length of stay in detox
Secondary outcomes
- Left against medical advice (AMA) - Reasons for leaving AMA - Placement in treatment at time of discharge

Cited by

No citation data available for this registration yet.

Keywords